| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.05 |